Breaking News

Pillar5 Pharma Expands Operations

August 23, 2013

Receives $1M from Eastern Ontario Development Fund

Pillar5 Pharma, Inc. has received $1 million from the Eastern Ontario Development Fund (EODF) to expand production at its Arnprior manufacturing facility, creating 56 new jobs and retaining 94 more in the community.
 
With support from EODF, Pillar5 will increase its operations by installing two new, advanced production lines for the manufacturing and packaging of eye care products. This expansion will better position the company to pursue new markets, both at home and abroad.
 
Dr. Eric Hoskins, Minister of Economic Development, Trade and Employment, said, “We are proud to be supporting job creation right here in eastern Ontario. This investment will help Pillar5 become a leader in the production of eye care products while expanding their markets and bringing new jobs and prosperity to the community of Arnprior.”
 
Kevin Rampton, chief executive officer of Pillar5 Pharma, commented, “We are thankful for the support from the Ontario government. This expansion means we can offer our customers more solutions for their pharmaceutical outsourcing needs. It also gives us greater capacity to increase production and explore new markets.”

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks